ASCO 2006

Robert Ozols William See Ruth Lupu Improving on Standard Treatment in Ovarian Cancer: Have We Hit a Wall? REFERENCE: Abstract 5002, 2006 ASCO Annual Meeting; N Engl J Med 2006, 354:34-43 ROBERT OZOLS,

Mark Socinski Bruce Johnson Neil Shah Doug Smith Sunitinib Multi-Targeted Oral Anti-Angiogenic Therapy Responses in Lung Cancer REFERENCE: Abstract 7001 Mark A. Socinski, Univerisity of North Carolina

Joan Houghton Elizabeth Barrett-Connor Fran Balkwill Carl Christophe Schimanski Adjuvant Anastrozole for Patients With Breast Cancer: Long-Term Safety Results From the ATAC Study REFERENCE: Lancet Onc

John Neoptolemos Wilko Weichert Christophe Nemos Pancreatic Cancer: Adjuvant Chemotherapy Improves Outlook for Patients with Resectable Tumors – ESPAC Trial Results REFERENCE: National Cancer Re

David Cunningham Kenneth MacDonald Mark Pomerantz Jorge Garcia REFERENCE: N Engl J Med 2006;355:11 David Cunningham, Royal Marsden Hospital The July 6th edition of the New England Journal of Me

Better Combine Chemotherapy with Radiation for Hodgkin’s Disease? Joachim Yahalom George Canellos REFERENCE: Education Session: Saturday June 3rd, 2006 ASCO Annual Meeting, June 2-6, Atla

Arlene Forastiere Everett Vokes Michael Skinner Mark Chambers Larynx Cancer: Concurrent Chemoradiotherapy: Best for Larynx Preservation REFERENCE: Abstract 5517 Arlene Forastiere, Sidney Kimmel Compre

Robert Ozols Lawrence Wickerham Patricia Ganz Jorma Paavonen Noah Kauff Robert Ozols of the Fox Chase Cancer Center in Philadelphia joins Derek Thorne to talk about the top presentations on cancer pre

Robert Mayer Thierry Facon Ibrahim Yakoub-Agha Peter Paschka Robert Mayer of the Dana-Farber Cancer Institute in Boston joins Derek Thorne to discuss the major hematologic malignancy news reported at

Dean Bajorin Robert Motzer Gary Hudes Marshall Posner Some major progress in kidney cancer and head and neck cancer was announced at the ASCO meeting in Atlanta, and the Audio Journal of Oncology has

Julie Gralow Charles Geyer Judith Bliss Robert Coleman Julie Gralow, from the Fred Hutchinson Cancer Research Center in Seattle, joins Derek Thorne to talk about the latest news from the ASCO annual m

George Canellos Carmela Pepe John Goldman Roy Herbst Sandra Horning George Canellos, from the Dana-Farber Cancer Institute in Boston, joins Derek Thorne to talk about the first day’s news at the

Bevacizumab: New Option for Breast Cancer REFERENCE: 5th European Breast Cancer Conference, Nice, 21st – 25th March 2006 Robin Zon, Michiana Hematology Oncology, South Bend, Indiana Bevacizumab

Myeloablative Radioimmunotherapy Eases Autologous Stem Cell Transplantations in Patients Age 60 years or Older With Relapsed or Refractory B-Cell Lymphoma ABSTRACT: 2005 American Society of Hematology

Tamoxifen After Chemotherapy Protects Premenopausal Patients with Breast Cancer ABSTRACT: J Clin Oncol 24:1322, 2006 Gordon McVie, European Institute of Oncology, Milan The use of tamoxifen after chem